Breakthrough for AlzeCure in the development of drugs for nerve pain
AlzeCure Pharma shows positive results from its clinical study with a new non-opioid drug candidate developed against peripheral neuropathic pain.
New data from AlzeCure’s phase IIa study show that the drug candidate ACD440 has a significant analgesic effect on pain induced by cold and heat.
– The medical need in this area is immense, not least to find alternatives to opioids. Neuropathic pain is the single largest market segment in pain management, generating over $11 billion in annual revenues. Up to 80 percent of all patients do not get a satisfactory effect with their current treatments, said AlzeCure Pharma’s CEO Martin Jönsson.
AlzeCure is among a handful of companies in the world that develop drugs that target the TRPV1 receptor, whose discovery was awarded the 2021 Nobel Prize in Medicine. The goal is to help people who suffer from nerve pain. In many cases today, there is no other effective treatment available than opioids, which both numb the whole body and can lead to addiction and substance abuse.
Agnes Török: A Voice for Performance Poetry & Reading Promotion
With roots in Sweden and an international career, Agnes Török has established themselves as one of the most engaging voices in modern poetry. Agnes Török is Sweden’s Reading Ambassador, a spoken word poet, and an author. Recently, they were also appointed as the lead instructor for the new university program in Performance Poetry and Storytelling at The Stockholm University College of Music Education (SMI).
GameHub Flemingsberg: A New Initiative to Create the Gaming Cluster of the Future
The Flemingsberg Science Foundation is launching a business development program in collaboration with Drivhuset Stockholm, associated partners, and Södertörn University as a first step in establishing a gaming cluster in Flemingsberg. The project, named GameHub, aims to facilitate the creation of new gaming companies and strengthen Flemingsberg’s position as a center for game development.
Södertörn University Invests in Social Innovation for Youth in Flemingsberg
Södertörn University has announced that they have been granted funding from the Swedish ESF Council to establish a competence center for social innovation. Flemingsberg continues its development as an innovation hub as researchers, students, and various stakeholders engage in efforts to combat social and economic vulnerability among young people in Södertörn.
Cluster Engine Flemingsberg – ERDF Project for Growth in Life Science
Flemingsberg is taking a significant step towards establishing itself as a central player in Life Science with the launch of the “Cluster Engine Life Science Flemingsberg” project. The project has been granted funding from the European Regional Development Fund (ERDF) and aims to strengthen the growth and establishment of small and medium-sized enterprises (SMEs) within the life science sector in the Stockholm region. The total project budget is €10.8 million for the years 2025–2027.
